Welcome to the Clara Nahmias’ lab Homepage

Clara Nahmias team is interested in studying cell-cell communication in normal and pathological situations, with a particular focus on the role of the angiotensin/ATIP axis and the microtubule cytoskeleton in breast cancer.

Seminal work of the team identified a novel family of proteins (ATIPs) initially isolated as interacting partners of the AT2 receptor. Recent studies led to the discovery that ATIP3 is a new anti-cancer molecule and a promising target for personalized therapies of aggressive breast cancer.

Clara Nahmias was awarded the ‘Prix du Ruban Rose Avenir’ in 2010 for these studies.

 This studies were recently highlighted in the Inserm Website:

"Breast Cancer: a protein prevents metastasis" > Read

Scientific news > Read